Immunomodulatory Research Peptides – True Peptide Labs Mon, 10 Aug 2026 17:08:53 +0000 en-US hourly 1 https://wordpress.org/?v=7.1 /wp-content/uploads/2025/07/cropped-Favicom-scaled-1-32x32.png Immunomodulatory Research Peptides – True Peptide Labs 32 32 246856718 ARA-290 – 10mg /product/ara-290-10mg/ /product/ara-290-10mg/#respond Mon, 06 Jul 2026 22:44:36 +0000 /?post_type=product&p=301495 ARA-290 (Cibinetide) is an 11-amino-acid synthetic peptide derived from the Helix B domain of erythropoietin (EPO), sequence QEQLERALNSS, CAS 1208243-50-8, MW ~1257.3. Supplied as a ≥99% HPLC-tested lyophilized powder — with a lot-specific third-party COA available before purchase — for in-vitro and laboratory research applications only. Research Use Only — not for human or veterinary use.

<p>The post ARA-290 – 10mg first appeared on True Peptide Labs.</p>

]]>
ARA-290, also referred to in the literature as Cibinetide, is an 11-amino-acid synthetic peptide corresponding to a sequence within the Helix B domain of the erythropoietin (EPO) molecule. Unlike full-length EPO, ARA-290 does not bind the classical EPO receptor and lacks erythropoietic activity; instead, it is studied in the research literature as a selective ligand of the innate repair receptor (IRR), a heteromeric complex composed of the EPO receptor and the common β-subunit (CD131).

This product is supplied as a lyophilized powder in 10 mg vials, synthesized to research grade, and characterized by HPLC (purity) and LC-MS (identity), with a lot-specific third-party Certificate of Analysis available before purchase. It is intended exclusively for in-vitro laboratory research and analytical applications.

In the research literature, ARA-290 is referenced as a tool compound used in the study of tissue-protective signaling, neuroregenerative research in cell-based models, and inflammatory pathway investigations related to the innate repair receptor complex.

<p>The post ARA-290 – 10mg first appeared on True Peptide Labs.</p>

]]>
/product/ara-290-10mg/feed/ 0 301495
VIP 5mg /product/vip-5mg/ /product/vip-5mg/#respond Tue, 02 Dec 2025 04:57:26 +0000 /?post_type=product&p=4440 <p>The post VIP 5mg first appeared on True Peptide Labs.</p>

]]>
<p>The post VIP 5mg first appeared on True Peptide Labs.</p>

]]>
/product/vip-5mg/feed/ 0 4440
Thymosin Alpha-1 10mg /product/thymosin-alpha-1-10mg/ /product/thymosin-alpha-1-10mg/#respond Tue, 21 Oct 2025 09:11:31 +0000 /?post_type=product&p=3393 Thymosin Alpha-1 (also known as TA-1, TA1, Tα1, thymalfasin) is a synthetic 28-amino-acid N-terminally acetylated peptide corresponding to the sequence of the endogenous thymic peptide first characterized in the Goldstein laboratory (CAS 62304-98-7, MW ~3108.3 g/mol). Supplied as a ≥99% HPLC-tested lyophilized powder, 10 mg per vial, for in-vitro and laboratory research applications only. Research Use Only — not for human or veterinary use.

<p>The post Thymosin Alpha-1 10mg first appeared on True Peptide Labs.</p>

]]>
Thymosin Alpha-1 — also referred to as TA-1, TA1, Tα1, and by the INN thymalfasin — is a synthetic 28-amino-acid N-terminally acetylated peptide corresponding to the amino-acid sequence of the endogenous thymic peptide first isolated and sequenced by the laboratory of Allan L. Goldstein (originally at Albert Einstein College of Medicine and later at George Washington University) from thymosin fraction 5. The peptide has an approximate molecular weight of 3108.3 g/mol and CAS number 62304-98-7.

This product is supplied as a lyophilized powder at 10 mg per vial, synthesized by solid-phase peptide synthesis (SPPS) and characterized by HPLC (purity) and LC-MS (identity). It is intended exclusively for in-vitro laboratory research and analytical applications.

In the research literature, Thymosin Alpha-1 is referenced as a synthetic peptide used as a tool compound in the study of Toll-like receptor pathways, particularly TLR9 and TLR2 signaling, and in comparative studies of thymic-derived peptides.

<p>The post Thymosin Alpha-1 10mg first appeared on True Peptide Labs.</p>

]]>
/product/thymosin-alpha-1-10mg/feed/ 0 3393
Hulk Blend(KPV 10mg/TB-500 25mg/BPC-157 10mg) /product/hulk-blend-kpv-10mg-tb-500-25mg-bpc-157-10mg/ /product/hulk-blend-kpv-10mg-tb-500-25mg-bpc-157-10mg/#comments Tue, 21 Oct 2025 09:09:03 +0000 /?post_type=product&p=3387 Hulk Blend is a three-component research peptide blend supplied as a single lyophilized preparation containing three synthetic peptides: KPV (Lys-Pro-Val tripeptide, 10 mg), BPC-157 (pentadecapeptide, 10 mg), and TB-500 (thymosin β4-referenced peptide, 25 mg) — 45 mg labeled total. Supplied for in-vitro and laboratory research applications only. Research Use Only — not for human or veterinary use.

<p>The post Hulk Blend(KPV 10mg/TB-500 25mg/BPC-157 10mg) first appeared on True Peptide Labs.</p>

]]>
<p>The post Hulk Blend(KPV 10mg/TB-500 25mg/BPC-157 10mg) first appeared on True Peptide Labs.</p>

]]>
/product/hulk-blend-kpv-10mg-tb-500-25mg-bpc-157-10mg/feed/ 4 3387
LL-37 5mg /product/ll-37-5mg/ /product/ll-37-5mg/#respond Tue, 19 Aug 2025 06:07:44 +0000 /?post_type=product&p=1886 <p>The post LL-37 5mg first appeared on True Peptide Labs.</p>

]]>
<p>The post LL-37 5mg first appeared on True Peptide Labs.</p>

]]>
/product/ll-37-5mg/feed/ 0 1886
KPV 10mg /product/kpv-10mg/ /product/kpv-10mg/#respond Tue, 05 Aug 2025 10:39:18 +0000 /?post_type=product&p=1520 <p>The post KPV 10mg first appeared on True Peptide Labs.</p>

]]>
<p>The post KPV 10mg first appeared on True Peptide Labs.</p>

]]>
/product/kpv-10mg/feed/ 0 1520